U.S. markets closed
  • S&P Futures

    3,654.75
    +31.50 (+0.87%)
     
  • Dow Futures

    29,871.00
    +242.00 (+0.82%)
     
  • Nasdaq Futures

    12,384.75
    +107.75 (+0.88%)
     
  • Russell 2000 Futures

    1,841.40
    +21.30 (+1.17%)
     
  • Crude Oil

    44.93
    -0.41 (-0.90%)
     
  • Gold

    1,786.30
    +5.40 (+0.30%)
     
  • Silver

    22.94
    +0.35 (+1.54%)
     
  • EUR/USD

    1.1962
    +0.0027 (+0.23%)
     
  • 10-Yr Bond

    0.8440
    +0.0020 (+0.24%)
     
  • Vix

    20.57
    -0.27 (-1.30%)
     
  • GBP/USD

    1.3356
    +0.0024 (+0.18%)
     
  • USD/JPY

    104.3520
    +0.0280 (+0.03%)
     
  • BTC-USD

    19,607.14
    +97.26 (+0.50%)
     
  • CMC Crypto 200

    384.85
    +20.25 (+5.56%)
     
  • FTSE 100

    6,266.19
    -101.39 (-1.59%)
     
  • Nikkei 225

    26,824.46
    +390.84 (+1.48%)
     

Vaccine Adjuvants Market 2020-2024- Featuring Agenus Inc., Avanti Polar Lipids Inc., Croda International Plc, Among Others

·3 min read

The vaccine adjuvants market is poised to grow by USD 401.94 mn during 2020-2024 progressing at a CAGR of 11% during the forecast period. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201106005405/en/

Technavio has announced its latest market research report titled Global Vaccine Adjuvants Market 2020-2024 (Graphic: Business Wire)

The report on the vaccine adjuvants market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the development of nanoparticle adjuvants.

The vaccine adjuvants market analysis includes the application segment and geography landscape. This study identifies the increase in awareness about immunization programs as one of the prime reasons driving the vaccine adjuvants market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The vaccine adjuvants market covers the following areas:

Vaccine Adjuvants Market Sizing

Vaccine Adjuvants Market Forecast

Vaccine Adjuvants Market Analysis

Companies Mentioned

  • Agenus Inc.

  • Avanti Polar Lipids Inc.

  • Croda International Plc

  • CSL Ltd.

  • GlaxoSmithKline Plc

  • InvivoGen

  • Merck KGaA

  • OZ Biosciences SAS

  • SEPPIC SA

  • Vaxine Pty Ltd.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem

  • Parent market

  • Market characteristics

  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition

  • Market sizing 2019

  • Market size and forecast 2019-2024

  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application

  • Comparison by application

  • Infectious diseases - Market size and forecast 2019-2024

  • Cancer - Market size and forecast 2019-2024

  • Other diseases - Market size and forecast 2019-2024

  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers

  • Market challenges

PART 11: MARKET TRENDS

  • Increase in R&D of novel vaccine adjuvants

  • Development of nanoparticle adjuvants

  • Rising number of collaborations

PART 12: VENDOR LANDSCAPE

  • Overview

  • Landscape disruption

  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered

  • Vendor classification

  • Market positioning of vendors

  • Agenus Inc.

  • Avanti Polar Lipids Inc.

  • Croda International Plc

  • CSL Ltd.

  • GlaxoSmithKline Plc

  • InvivoGen

  • Merck KGaA

  • OZ Biosciences SAS

  • SEPPIC SA

  • Vaxine Pty Ltd.

PART 14: APPENDIX

  • Research methodology

  • List of abbreviations

  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201106005405/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/